BKYI BIO KEY International (BKYI) Insider Trading, Ownership & Congress Trades
Software & IT · Services-prepackaged software · CIK 0001019034
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
BIO KEY International insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for BIO KEY INTERNATIONAL INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 18 earlier Form 4 trades (code P or S) here by this insider (18 buys), the last on Sep 15, 2025.
- -17.9% median (-27.8% mean) 90-day return after 15 previous buys.
- The trade is 1.6% of the 102,775 shares held after it.
- 1 other insider bought within 30 days.
Insider activity: Chief Executive Officer DEPASQUALE MICHAEL W bought about $1.4K of BKYI on Sep 16, 2025; 1 other insider bought within 30 days.Context
- 18 earlier Form 4 trades (code P or S) here by this insider (18 buys), the last on Sep 15, 2025.
- -17.9% median (-27.8% mean) 90-day return after 15 previous buys.
- The trade is 1.4% of the 112,174 shares held after it.
- 1 other insider bought within 30 days.
Insider activity: Chief Executive Officer DEPASQUALE MICHAEL W bought about $1.4K of BKYI on Sep 16, 2025; 1 other insider bought within 30 days.Context
- 16 earlier Form 4 trades (code P or S) here by this insider (16 buys), the last on Jun 13, 2025.
- -20.6% median (-28.5% mean) 90-day return after 14 previous buys.
- The trade is 2.5% of the 101,158 shares held after it.
- 1 other insider bought within 30 days.
Insider activity: Chief Executive Officer DEPASQUALE MICHAEL W bought about $1.9K of BKYI on Sep 15, 2025; 1 other insider bought within 30 days.Context
- 16 earlier Form 4 trades (code P or S) here by this insider (16 buys), the last on Jun 13, 2025.
- -20.6% median (-28.5% mean) 90-day return after 14 previous buys.
- The trade is 2.3% of the 110,557 shares held after it.
- 1 other insider bought within 30 days.
Insider activity: Chief Executive Officer DEPASQUALE MICHAEL W bought about $1.9K of BKYI on Sep 15, 2025; 1 other insider bought within 30 days.Context
- 27 earlier Form 4 trades (code P or S) here by this insider (27 buys), the last on Nov 30, 2023.
- -36.6% median (-37.0% mean) 90-day return after 14 previous buys.
- The trade is 18.2% of the 54,851 shares held after it.
- 1 other insider bought within 30 days.
Insider activity: Chief Legal Officer Sullivan James David bought about $7.7K of BKYI on Aug 22, 2025, the largest insider purchase at the company since 2023; 1 other insider bought within 30 days.49 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
-14.3% year over year
below 85% of Software & IT
Margin
-120.6% net margin
below 86% of Software & IT
Buybacks
no share repurchases reported
Short interest
28.6% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
more than 98% of Software & IT
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch BKYI
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-64.0%12M
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns BKYI: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in BKYI
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
BKYI planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Michael W. DePasquale
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$346.8K
$309.4K
$348.2K
-95%
n/a
2024
$309.5K
$277.1K
$273.6K
-84%
n/a
2023
$291.5K
$261.3K
$221.6K
-72%
n/a
2022
$372.1K
$254.5K
$336.2K
-74%
n/a
2021
$276.9K
$265.9K
$227.3K
-37%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
BKYI financials
Revenue growth
-14.3%
XBRL, annual
Net margin
-120.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.7M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM BKYI
| FY Dec 2025 | $5.9M |
| FY Dec 2024 | $6.9M |
| FY Dec 2023 | $7.8M |
| FY Dec 2022 | $7.0M |
| FY Dec 2021 | $5.1M |
| Jun 2026 | $1.9M |
| Mar 2026 | $2.1M |
| Dec 2025 | $1.1M |
| Sep 2025 | $1.5M |
| Jun 2025 | $1.7M |
| Mar 2025 | $1.6M |
| Dec 2024 | $1.5M |
| Sep 2024 | $2.1M |
At each fiscal year end
Single quarter
Net margin, TTM
+123.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM BKYI
| FY Dec 2025 | +120.6% |
| FY Dec 2024 | +62.1% |
| FY Dec 2023 | n/a |
| FY Dec 2022 | -169.7% |
| FY Dec 2021 | -99.0% |
| Jun 2026 | -30.0% |
| Mar 2026 | -9.6% |
| Dec 2025 | +925.2% |
| Sep 2025 | -62.3% |
| Jun 2025 | -68.8% |
| Mar 2025 | -45.8% |
| Dec 2024 | +493.5% |
| Sep 2024 | -34.5% |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$4.2M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM BKYI
| FY Dec 2025 | -$4.7M |
| FY Dec 2024 | -$2.9M |
| FY Dec 2023 | -$3.8M |
| FY Dec 2022 | -$6.3M |
| FY Dec 2021 | -$9.0M |
| Jun 2026 | -$845.7K |
| Mar 2026 | -$358.0K |
| Dec 2025 | -$1.8M |
| Sep 2025 | -$1.1M |
| Jun 2025 | -$881.5K |
| Mar 2025 | -$839.9K |
| Dec 2024 | -$504.6K |
| Sep 2024 | -$1.3M |
At each fiscal year end
Single quarter
Debt to equity
0.03x
long-term 2025-06-30 (12 months older than the period end) plus current 2024-03-31 (27 months older than the period end); equity 2026-06-30
Debt to equity BKYI
| FY Dec 2025 | 0.03x |
| FY Dec 2024 | 0.05x |
| FY Dec 2023 | 0.31x |
| FY Dec 2022 | 0.08x |
| FY Dec 2021 | 0.00x |
| Jun 2026 | 0.03x |
| Mar 2026 | 0.03x |
| Dec 2025 | 0.03x |
| Sep 2025 | 0.02x |
| Jun 2025 | 0.02x |
| Mar 2025 | 0.02x |
| Dec 2024 | 0.05x |
| Sep 2024 | 1.65x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-30.60x
TTM operating cash flow over long-term 2025-06-30 (12 months older than the period end) plus current 2024-03-31 (27 months older than the period end)
Cash flow to debt BKYI
| FY Dec 2025 | -34.37x |
| FY Dec 2024 | -16.14x |
| FY Dec 2023 | -11.58x |
| FY Dec 2022 | -13.94x |
| FY Dec 2021 | n/a |
| Jun 2026 | -30.60x |
| Mar 2026 | -30.86x |
| Dec 2025 | -34.37x |
| Sep 2025 | -24.68x |
| Jun 2025 | -25.81x |
| Mar 2025 | -27.43x |
| Dec 2024 | -16.14x |
| Sep 2024 | -17.89x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+148.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity BKYI
| FY Dec 2025 | +161.2% |
| FY Dec 2024 | +177.9% |
| FY Dec 2023 | n/a |
| FY Dec 2022 | -113.9% |
| FY Dec 2021 | -28.2% |
| Jun 2026 | +148.0% |
| Mar 2026 | +123.8% |
| Dec 2025 | +161.2% |
| Sep 2025 | +140.8% |
| Jun 2025 | +157.8% |
| Mar 2025 | +101.1% |
| Dec 2024 | +177.9% |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+92.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets BKYI
| FY Dec 2025 | +84.6% |
| FY Dec 2024 | +65.5% |
| FY Dec 2023 | n/a |
| FY Dec 2022 | -81.8% |
| FY Dec 2021 | -25.1% |
| Jun 2026 | +92.0% |
| Mar 2026 | +79.5% |
| Dec 2025 | +84.6% |
| Sep 2025 | +52.7% |
| Jun 2025 | +59.7% |
| Mar 2025 | +53.1% |
| Dec 2024 | +65.5% |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital BKYI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-101.1%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed BKYI
| FY Dec 2025 | -147.3% |
| FY Dec 2024 | -149.5% |
| FY Dec 2023 | -245.4% |
| FY Dec 2022 | -91.6% |
| FY Dec 2021 | -27.1% |
| Jun 2026 | -101.1% |
| Mar 2026 | -100.0% |
| Dec 2025 | -147.3% |
| Sep 2025 | -101.2% |
| Jun 2025 | -115.1% |
| Mar 2025 | -96.7% |
| Dec 2024 | -149.5% |
| Sep 2024 | -257.2% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing BKYI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.7M
market value at close 2026-10-27 on 2026-08-11 shares, plus long-term 2025-06-30 (12 months older than the period end) plus current 2024-03-31 (27 months older than the period end), minus cash 2026-06-30
Enterprise value BKYI
| FY Dec 2025 | $56.0M |
| FY Dec 2024 | $53.2M |
| FY Dec 2023 | $411.8M |
| FY Dec 2022 | $896.8M |
| FY Dec 2021 | $3.1B |
| Jun 2026 | $3.7M |
| Mar 2026 | $55.3M |
| Dec 2025 | $56.0M |
| Sep 2025 | $47.5M |
| Jun 2025 | $45.6M |
| Mar 2025 | $21.7M |
| Dec 2024 | $53.2M |
| Sep 2024 | $17.4M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-106.0%
TTM free cash flow over market value at close 2026-10-27
FCF yield BKYI
| FY Dec 2025 | -8.0% |
| FY Dec 2024 | -5.5% |
| FY Dec 2023 | -0.9% |
| FY Dec 2022 | -0.7% |
| FY Dec 2021 | -0.3% |
| Jun 2026 | -85.0% |
| Mar 2026 | -7.3% |
| Dec 2025 | -8.0% |
| Sep 2025 | -6.8% |
| Jun 2025 | -7.4% |
| Mar 2025 | -16.4% |
| Dec 2024 | -5.5% |
| Sep 2024 | -20.8% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing BKYI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $5.9M | $6.9M | $7.8M | $7.0M |
| Gross profit | $4.6M | $5.6M | $1.4M | $4.6M |
| Operating income | -$6.8M | -$4.0M | -$8.8M | -$9.9M |
| Net income | $7.2M | $4.3M | $8.5M | -$11.9M |
| Operating cash flow | -$4.7M | -$2.9M | -$3.8M | -$6.2M |
| Cash | $2.7M | $437.6K | $511.4K | $2.6M |
| Long-term debt | n/a | $44.8K | $188.8K | $326.8K |
SEC XBRL, fiscal years, as known on 2026-10-28
BKYI Stock Sonar score 4/7 axes
Find similar shapesCompareBKYI ranks highest on profitability (68th percentile) and financial health (37th), and lowest on growth (15th), among Software & IT peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
